Detalle Publicación

ARTÍCULO

Zolmitriptan: A novel portal hypotensive agent which synergizes with propranolol in lowering Portal Pressure

Título de la revista: PLOS ONE
ISSN: 1932-6203
Volumen: 8
Número: 1
Páginas: e52683
Fecha de publicación: 2013
Resumen:
Zolmitriptan reduces portal hypertension and non-selective beta-blockers can improve this effect. Combination therapy deserves consideration for patients with portal hypertension failing to respond to non-selective beta-blockers.
Impacto: